Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DNA XSONM -6.88%35 FCF Yield % is -331.86 as of Aug. 10, 2026. GuruFocus rates SONM with a GF Score™ of 35/100 and a GF Value™ of $29.79 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 808 Capital Markets companies, DNA X ranks worse than 98.64% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, DNA X's Trailing 12-Month Free Cash Flow is $-17.39 Mil, and Market Cap is $5.24 Mil. Therefore, DNA X's FCF Yield % for today is -331.86%.
The historical rank and industry rank for DNA X's FCF Yield % or its related term are showing as below:
SONM'
s FCF Yield % Range Over the Past 10 Years
Min: -801.08 Med: -60.74 Max: 23.8
Current: -331.86
During the past 9 years, the highest FCF Yield % of DNA X was 23.80%. The lowest was -801.08%. And the median was -60.74%.
SONM's FCF Yield % is ranked worse than 98.64% of 808
companies
in the Capital Markets industry
Industry Median: -0.17
vs SONM: -331.86
DNA X's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
DNA X FCF Yield % Related Terms
DNA X FCF Yield % Historical Data
* Premium members only.
The historical data trend for DNA X's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Capital Markets subindustry, DNA X's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DNA X FCF Yield % vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, DNA X's FCF Yield % distribution charts can be found below:
* The bar in red indicates where DNA X's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DNA X (SONM) has a FCF Yield % of -331.86 as of Aug. 10, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on DNA X and its competitors. According to the industry distribution chart, DNA X ranks #797 out of 808 companies in the Capital Markets industry, placing it in the top 98.6%.
Is DNA X's FCF Yield % too high?
DNA X's current FCF Yield % is -331.86. Based on the distribution chart, DNA X ranks #797 out of 808 companies in the Capital Markets industry, which is in the bottom quartile relative to peers. Overall, DNA X has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does DNA X's FCF Yield % compare to CETX and OLB?
According to the Capital Markets industry distribution chart, DNA X ranks #797 out of 808 companies for FCF Yield %. This places DNA X in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Capital Markets company?
A good FCF Yield % depends on the Capital Markets industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on DNA X and its competitors. DNA X's current FCF Yield % is -331.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DNA X stock overvalued right now?
Based on GuruFocus' analysis, DNA X (SONM) is currently considered Possible Value Trap. The stock's GF Value™ is $29.79, compared to a current price of $3.52 — trading 88.2% below its estimated fair value. The current FCF Yield % is -331.86. DNA X's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For DNA X (SONM), the current FCF Yield % is -331.86 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DNA X (SONM) Overvalued in 2026?
Based on GuruFocus' analysis, DNA X stock appears to be undervalued.
The current stock price of $3.52 is trading 88.2% below its estimated GF Value™ of $29.79.
GuruFocus considers DNA X to be Possible Value Trap.
Key valuation signals for SONM:
FCF Yield %: -331.86
GF Value™: $29.79 vs. price of $3.52 (88.2% below fair value)
No single metric tells the full story. See the SONM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.
35GF Score
Get the complete analysis for SONM
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SONM has been successfully added to your 
